Logo image of DOX.MI

DOXEE SPA (DOX.MI) Stock Fundamental Analysis

BIT:DOX - Euronext Milan - IT0005394413 - Common Stock - Currency: EUR

1.55  -0.03 (-1.9%)

Fundamental Rating

2

Overall DOX gets a fundamental rating of 2 out of 10. We evaluated DOX against 101 industry peers in the Software industry. DOX may be in some trouble as it scores bad on both profitability and health. DOX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DOX has reported negative net income.
DOX had a positive operating cash flow in the past year.
DOX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years DOX had a positive operating cash flow.
DOX.MI Yearly Net Income VS EBIT VS OCF VS FCFDOX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

With a Return On Assets value of -9.66%, DOX is not doing good in the industry: 79.07% of the companies in the same industry are doing better.
The Return On Equity of DOX (-42.86%) is worse than 82.56% of its industry peers.
Industry RankSector Rank
ROA -9.66%
ROE -42.86%
ROIC N/A
ROA(3y)-1.48%
ROA(5y)1.53%
ROE(3y)-19.24%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
DOX.MI Yearly ROA, ROE, ROICDOX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 2K 4K 6K

1.3 Margins

Looking at the Gross Margin, with a value of 61.63%, DOX is doing worse than 63.95% of the companies in the same industry.
DOX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DOX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-7.14%
DOX.MI Yearly Profit, Operating, Gross MarginsDOX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

DOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DOX has less shares outstanding
The number of shares outstanding for DOX has been increased compared to 5 years ago.
Compared to 1 year ago, DOX has a worse debt to assets ratio.
DOX.MI Yearly Shares OutstandingDOX.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
DOX.MI Yearly Total Debt VS Total AssetsDOX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.25, we must say that DOX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.25, DOX is not doing good in the industry: 83.72% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.31 is on the high side and indicates that DOX has dependencies on debt financing.
With a Debt to Equity ratio value of 1.31, DOX is not doing good in the industry: 86.05% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACCN/A
WACC8.46%
DOX.MI Yearly LT Debt VS Equity VS FCFDOX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.66 indicates that DOX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.66, DOX is doing worse than 91.86% of the companies in the same industry.
DOX has a Quick Ratio of 0.66. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
DOX has a worse Quick ratio (0.66) than 90.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
DOX.MI Yearly Current Assets VS Current LiabilitesDOX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

DOX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.05%.
Looking at the last year, DOX shows a small growth in Revenue. The Revenue has grown by 5.33% in the last year.
DOX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.47% yearly.
EPS 1Y (TTM)-20.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44%
Revenue 1Y (TTM)5.33%
Revenue growth 3Y13.43%
Revenue growth 5Y13.47%
Sales Q2Q%3.22%

3.2 Future

DOX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.84% yearly.
Based on estimates for the next years, DOX will show a quite strong growth in Revenue. The Revenue will grow by 13.10% on average per year.
EPS Next Y30.2%
EPS Next 2Y42.87%
EPS Next 3Y34.84%
EPS Next 5YN/A
Revenue Next Year18.71%
Revenue Next 2Y14.6%
Revenue Next 3Y13.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DOX.MI Yearly Revenue VS EstimatesDOX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DOX.MI Yearly EPS VS EstimatesDOX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DOX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 76.73 indicates a quite expensive valuation of DOX.
66.28% of the companies in the same industry are cheaper than DOX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DOX to the average of the S&P500 Index (22.10), we can say DOX is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 76.73
DOX.MI Price Earnings VS Forward Price EarningsDOX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

63.95% of the companies in the same industry are cheaper than DOX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.02
DOX.MI Per share dataDOX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DOX's earnings are expected to grow with 34.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.87%
EPS Next 3Y34.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DOX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOXEE SPA

BIT:DOX (3/7/2025, 7:00:00 PM)

1.55

-0.03 (-1.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.59%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.81M
Analysts80
Price Target6.86 (342.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-322.15%
EPS NY rev (3m)-461.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 76.73
P/S 0.68
P/FCF N/A
P/OCF 4.14
P/B 1.79
P/tB N/A
EV/EBITDA 41.02
EPS(TTM)-0.42
EYN/A
EPS(NY)0.02
Fwd EY1.3%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.37
OCFY24.15%
SpS2.28
BVpS0.87
TBVpS-1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.66%
ROE -42.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.63%
FCFM N/A
ROA(3y)-1.48%
ROA(5y)1.53%
ROE(3y)-19.24%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-7.14%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Debt/EBITDA 15.95
Cap/Depr 163.57%
Cap/Sales 29.99%
Interest Coverage N/A
Cash Conversion 527.11%
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 0.25
F-Score5
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)25.66%
Cap/Sales(5y)24.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44%
EPS Next Y30.2%
EPS Next 2Y42.87%
EPS Next 3Y34.84%
EPS Next 5YN/A
Revenue 1Y (TTM)5.33%
Revenue growth 3Y13.43%
Revenue growth 5Y13.47%
Sales Q2Q%3.22%
Revenue Next Year18.71%
Revenue Next 2Y14.6%
Revenue Next 3Y13.1%
Revenue Next 5YN/A
EBIT growth 1Y-131.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2401.49%
EBIT Next 3Y258.47%
EBIT Next 5YN/A
FCF growth 1Y-201.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.01%
OCF growth 3Y-24.68%
OCF growth 5Y-0.09%